405
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Breast Cancer in Italy: Stage and Region Distribution

, , , , , , , , , , & show all
Pages 125-131 | Published online: 29 Apr 2022

References

  • AIOM-AIRTUM-SIAPEC-IAP. I numeri del cancro in Italia, 2020. Intermedia Editor; 2020.
  • International Agency for Research on Cancer. Breast cancer: estimated incidence, mortality and prevalence worldwide in 2012; 2015. Available from: http://globocan.iarc.fr/old/FactSheets/cancers/breast-new.asp. Accessed October 23, 2017.
  • Cardoso F, Costa A, Senkus E, et al. 3rd ESO-ESMO international consensus guidelines for Advanced Breast Cancer (ABC 3). Breast. 2017;31:244–259. doi:10.1016/j.breast.2016.10.001
  • Cardoso F, Costa A, Norton L, et al. 1st International consensus guidelines for advanced breast cancer (ABC 1). Breast. 2012;21(3):242–252. doi:10.1016/j.breast.2012.03.003
  • Unger-Saldana K. Challenges to the early diagnosis and treatment of breast cancer in developing countries. World J Clin Oncol. 2014;5(3):465–477. doi:10.5306/wjco.v5.i3.465
  • Lee T, Isaacs C. Treatment of primary breast tumors in de novo metastatic breast cancer. Clin Adv Hematol Oncol. 2014;12:820e7.
  • Mangone L, Mancuso P, Tagliabue G, et al. Neoadjuvant therapy for breast cancer. Tumori. 2019;105(6):488–493. doi:10.1177/0300891619869505
  • Mangone L, Mancuso P, Bisceglia I, et al. Five-year relative survival by stage of breast and colon cancers in Italy. Tumori. 2021;107(4):318–324. PMID: 33153410. doi:10.1177/0300891620964565
  • Tagliabue G, Fabiano S, Contiero P, et al. Airtum working group. molecular subtypes, metastatic pattern and patient age in breast cancer: an analysis of Italian network of cancer registries (AIRTUM) data. J Clin Med. 2021;10(24):5873. PMID: 34945169 PMCID: PMC8706111. doi:10.3390/jcm10245873
  • Mangone L, Ferrari F, Mancuso P, et al. Epidemiology and biological characteristics of male breast cancer in Italy. Breast Cancer. 2020;27(4):724–731. PMID: 32114665. doi:10.1007/s12282-020-01068-1
  • Sledge GW Jr. Curing metastatic breast cancer. J Oncol Pract. 2016;12(1):6–10. PMID: 26759458. doi:10.1200/JOP.2015.008953
  • Turner NC, Slamon DJ, Ro J, et al. Overall survival with palbociclib and fulvestrant in advanced breast cancer. N Engl J Med. 2018;379(20):1926–1936. PMID: 30345905. doi:10.1056/NEJMoa1810527
  • Hortobagyi GN. First line cdk 4–6 inhibition shows overall survival benefit for metastatic breast cancer. ESMO Congress; 2021.
  • Howlader N, Noone AM, Krapcho M, et al. SEER fast stats, 1975–2014. Stage Distrib. 2018;2018:2005–2014.
  • AIOM-AIRTUM. I numeri del cancro in Italia, 2016. Il pensiero scientifico editore; 2016.
  • World Health Organization. Available from: https://www.who.int/. Accessed April 21, 2022.
  • Coviello V, Buzzoni C, Fusco M, et al. AIRTUM working group. Survival of cancer patients in Italy. Epidemiol Prev. 2017;41(2Suppl 1):1–244. PMID: 28629213. doi:10.19191/EP17.2S1
  • Patel G, Kishore Reddy BV, Patil P. Is surgical management of primary beneficial in metastatic breast cancer? Indian J Surg Oncol. 2021;12(2):421–427. doi:10.1007/s13193-021-01329-1
  • National Screening Observatory. Osservatorio Nazionale Screening: i programmi, gli operatori, le evidenze scientifiche, i risultati. [National Screening Observatory: programs, operators, scientific evidence, results]. Available from: https://www.osservatorionazionalescreening.it/. Accessed April 21, 2022. Italian.
  • Liang Y, Zhang H, Song X, Yang Q. Metastatic heterogeneity of breast cancer: molecular mechanism and potential therapeutic targets. Semin Cancer Biol. 2020;60:14–27. PMID: 31421262. doi:10.1016/j.semcancer.2019.08.012
  • Tometich DB, Hyland KA, Soliman H, Jim HSL, Oswald L. Living with metastatic cancer: a roadmap for future research. Cancers. 2020;12(12):3684. doi:10.3390/cancers12123684
  • Tosello G, Torloni MG, Mota BS, Neeman T, Riera R. Breast surgery for metastatic breast cancer. Cochrane Database Syst Rev. 2018;3(3):CD011276. PMID: 29542106 PMCID: PMC6494198. doi:10.1002/14651858.CD011276
  • Kent CL, Mc Duff SGR, Salama JK. Oligometastatic breast cancer: where are we now and where are we headed?-a narrative review. Ann Palliat Med. 2021;10(5):5954–5968. doi:10.21037/apm-20-1128
  • Lu P, Santa-Maria CA, Ballinger TJ, Sheng JY. Landmark trials in the medical oncology management of metastatic breast cancer. Semin Oncol. 2021;48(3):246–258. doi:10.1053/j.seminoncol.2021.06.003